The five candidate markers were GATA3, KRT20, and uroplakin 2 (luminal) as well as KRT5/6 and KRT14 (basal) also routinely used in diagnostic workup of bladder tumor samples. This evidence concerns the gene KRT20 and urinary bladder neoplasm.